RecallRadar

FDA Drug recall D-0987-2020

Triamcinolone Acetonide (PF) Injectable Suspension, TRIAMCINOLONE ACETONIDE (PF) [2ML] 40MG/ML INJ SUSP, For IM, IA, IT Use, 2 mL Single Us…

On 2020-03-11 the FDA classified a Class II recall of Triamcinolone Acetonide (PF) Injectable Suspension, TRIAMCINOLONE ACETONIDE (PF) [2ML] 40MG/ML INJ SUSP, For IM, IA, IT Use, 2 mL Single Us… by Fusion Iv Pharmaceuticals, citing lack of Assurance of Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0987-2020
ClassificationClass II
Statusterminated
Initiated2020-01-15
Published2020-03-11
Last updated2026-09-13 11:52 UTC
CompanyFusion Iv Pharmaceuticals
DistributionUS

Product

Triamcinolone Acetonide (PF) Injectable Suspension, TRIAMCINOLONE ACETONIDE (PF) [2ML] 40MG/ML INJ SUSP, For IM, IA, IT Use, 2 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0635-2

Reason

Lack of Assurance of Sterility

Identifiers

code_infoLot #: 08272019+52841, Exp 2/22/2020; 09242019+52953, Exp 3/22/2020; 11072019+53198, Exp 5/5/2020; 11112019+53206, Exp 5/9/2020; 11122019+53223, Exp 5/10/2020

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0987-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.